Thanks @AgendaGerut for featuring us in Fortune magazine!
“Everyone has a unique family history, so we don’t have one type of customer,” Christensen told Fortune. Sometimes a prospective parent will come to the firm, excited about screening embryos for IQ, and then they’ll discover a BRCA gene mutation, which can increase the risk of breast and ovarian cancers. Then that becomes the top priority in screening embryos, said Christensen."
Today parents can, for the first time, access polygenic embryo testing for IQ and many diseases through a routine test (PGT-A) done worldwide and in 60% of US IVF cycles.
Read on to learn how Herasight’s ImputePGTA algorithm is enabling polygenic testing in IVF to go global. 🧵
"A recent paper from Google’s DeepMind found that agents learned better when allowed to construct a model of the world themselves...rather than trying to make sense of the ‘real’ world in which it found itself." A fascinating blog by physicist Adam Elwood. https://t.co/c5r1PzAH1c
Calling all entrepreneurs! @RebelBio is looking for ambitious #scientists who want to use their knowledge to build great startups & change the world! Apply here for up to $275k in #funding & years of #support - https://t.co/ZjUmFSJTA5
Grotesk, at en sygehusafd. straffes økonomisk, hvis den til gavn for patienten f.eks. samler flere speciallægebesøg til ét besøg. Sundhedsvæsenet skal styres efter det, der giver størst værdi for patienterne #værdibaseretsundhed#værdiforpatienten#sundpol https://t.co/yveYnW7HRN